{"id":24341,"date":"2012-06-12T01:29:30","date_gmt":"2012-06-12T05:29:30","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=24341"},"modified":"2012-06-12T14:59:14","modified_gmt":"2012-06-12T18:59:14","slug":"things-just-dont-change","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2012\/06\/12\/things-just-dont-change\/","title":{"rendered":"things just don&#8217;t change&#8230;"},"content":{"rendered":"<br \/>\n<blockquote>\n<div align=\"center\"><a href=\"http:\/\/www.miamiherald.com\/2012\/06\/10\/2843932\/medical-advances-helping-lift.html\" target=\"_blank\"><u><strong><font color=\"#200020\">Medical advances helping lift the fog of depression<\/font><\/strong><\/u><\/a><br \/>  <strong><font color=\"#200020\"><sup>Women are twice as likely than men to develop depression. New treatments are in the works.<\/sup><\/font><\/strong><br \/>  <strong><font color=\"#200020\">The Miami Herald<\/font><\/strong><br \/>  By Lidia Dinkova<br \/>  June 12, 2012 <\/div>\n<p>  <\/p>\n<div align=\"justify\"><sup>About 20 years ago, Sue gave the impression that she was the  poster college girl. She was pretty, slim, in a sorority, and frequented  bars and parties. But beneath that surface was a woman in her 20s struggling with depression, a condition that she has lived with until recently&#8230;<\/p>\n<p>   Sue  is hardly an isolated case. Worldwide, women are twice as likely to  develop depression than men, said Dr. Charles Nemeroff, chairman of the  Department of Psychiatry and Behavioral Sciences at the University of  Miami Miller School of Medicine.&nbsp; In the U.S. alone, one in five  women will have a major depressive episode in their life. After puberty,  women are more likely to get depression than men. Particularly risky  phases are after childbirth, commonly known as postpartum depression,  and during menopause. &ldquo;Not any single one of these factors may be  the reason why women may be more vulnerable. But when you put them  together, they probably conspire to increase the risk,&rdquo; Nemeroff said. The options: Vagus  nerve stimulation, repetitive transcranial magnetic stimulation and  deep brain stimulation are options available for patients who have not  responded to other treatments, Nemeroff said. The vagus nerve  stimulation treatment was originally approved by the Food and Drug  Administration in 1997 for the treatment of epilepsy. In 2005, the FDA  approved it for depression in cases where patients were not responsive  to other treatments. A battery-powered generator similar to a  pacemaker is implanted in the chest. A wire connected to the generator  travels to the vagus nerve in the neck, where it sends electrical  impulses to mood centers in the brain. The FDA approved  repetitive transcranial magnetic stimulation in 2008. An electromagnet  is placed on the scalp and magnetic pulses are sent from outside the  skull to a small surface area of the brain. This type of treatment will  soon be an option for patients at UM.<\/p>\n<p>   Deep  brain stimulation has not been FDA approved for the treatment of  depression but it has been approved for Parkinson&rsquo;s disease and  obsessive-compulsive disorder. It is offered to UM patients on a  case-by-case basis. A hole is drilled in the skull and minuscule  electrodes are lowered through a catheter into the brain area that  affects mood. A generator is implanted under the chest skin to control  the amount of brain stimulation. Only about 150 depression patients in  the world have been treated with deep brain stimulation, Nemeroff said.<\/p>\n<p>   A  year ago, the FDA approved Viibryd, a drug that increases serotonin  levels in the brain by stimulating the brain&rsquo;s serotonin receptors.  Serotonin is a chemical produced by the body that allows brain cells and  other nervous system cells to communicate with each other. Low  serotonin levels have been linked to depression. Studies also are  under way in which patients are given ketamine intravenously, a drug  originally used as a tranquilizer by veterinarians. The FDA has not  approved ketamine for treating depression. &ldquo;It&rsquo;s a whole new avenue of investigation,&rdquo; Nemeroff said&#8230;<\/sup><\/div>\n<\/blockquote>\n<div align=\"justify\">Literally, the minute I pushed the publish button on the last post, this Google alert popped up. It reads like one of those <em>recent-advances-in<\/em> or <em>neurobiology-of<\/em> articles that filled our literature. It&#8217;s starts with the signature public health intro and even has the same old treatments: <a target=\"_blank\" href=\"http:\/\/www.ahrp.org\/cms\/content\/view\/345\/55\/\"><u><strong><font color=\"#200020\">VNS<\/font><\/strong><\/u><\/a> Stimulation, that treatment that Nemeroff pushed in the Journal he edited, the one that got him fired in 2006 for omitting his financial interests. Then he mentions the treatments he was into at Emory, Transcranial Magnetism and Dr. Mayberg&#8217;s brain electrodes. The Forest Laboratories <a target=\"_blank\" href=\"http:\/\/1boringoldman.com\/index.php\/2011\/10\/31\/viibryd-i\/\"><u><strong><font color=\"#200020\">Viibryd<\/font><\/strong><\/u><\/a>, a me-too SSRI floating around for years. I haven&#8217;t heard &quot;low  serotonin levels have been linked to depression&quot; for a long time, echos of the &quot;chemical imbalance&quot; line from the 1990s. And Ketamine? It&#8217;s like a revival of one of those old review articles, but in the local Miami newspaper where there are no Conflict of Interest statement requirements instead of a journal article.<\/div>\n<p>   <\/p>\n<div align=\"justify\">Things just don&#8217;t change&#8230;<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Medical advances helping lift the fog of depression Women are twice as likely than men to develop depression. New treatments are in the works. The Miami Herald By Lidia Dinkova June 12, 2012 About 20 years ago, Sue gave the impression that she was the poster college girl. She was pretty, slim, in a sorority, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-24341","post","type-post","status-publish","format-standard","hentry","category-politics"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/24341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=24341"}],"version-history":[{"count":9,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/24341\/revisions"}],"predecessor-version":[{"id":24366,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/24341\/revisions\/24366"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=24341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=24341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=24341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}